Clinical improvement with JAK2 inhibition in Chuvash polycythemia
AW Zhou, EM Knoche, EK Engle… - … England Journal of …, 2016 - Mass Medical Soc
AW Zhou, EM Knoche, EK Engle, M Ban-Hoefen, C Kaiwar, ST Oh
New England Journal of Medicine, 2016•Mass Medical SocClinical Improvement with JAK2 Inhibition in Chuvash Polycythemia | NEJM Skip to main content
NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a
physician, build your knowledge, lead a health care organization, and advance your career with
NEJM Group information and services. NEJM Evidence NEW! A digital journal for innovative
original research and fresh, bold ideas in clinical trial design and clinical decision-making.
NEJM Catalyst NEW! Peer-reviewed journal featuring in-depth articles to accelerate the …
NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a
physician, build your knowledge, lead a health care organization, and advance your career with
NEJM Group information and services. NEJM Evidence NEW! A digital journal for innovative
original research and fresh, bold ideas in clinical trial design and clinical decision-making.
NEJM Catalyst NEW! Peer-reviewed journal featuring in-depth articles to accelerate the …
Rare mutations in the VHL gene may lead to polycythemia in children. Ruxolitinib resulted in clinical improvement in three people with this disorder.
The New England Journal Of Medicine